Literature DB >> 8611101

Antibiotic-resistant enterococci and the changing face of surgical infections.

M E de Vera1, R L Simmons.   

Abstract

BACKGROUND: Enterococci have not been thought to play an important role in intra-abdominal infections because of their relatively low virulence. However, this notion is changing because of the recent emergence of these microbes as significant nosocomial pathogens.
OBJECTIVES: To review the mechanisms of antibiotic resistance of enterococci and to discuss the significance of multidrug-resistant enterococci in surgical infections. DATA SOURCES: Medical and basic science literature relating to enterococci. DATA SYNTHESIS: In addition to having intrinsic resistance to a number of antibiotics, enterococci have the ability to acquire resistant genes through the exchange of plasmids or transposons from other bacterial species. Moreover, enterococci have been shown to transmit these genes to other bacterial species in turn. The extensive resistance of these microorganisms has led to their emergence as significant nosocomial pathogens, ranking second only to Escherichia coli in the number of pathogenic isolates recovered from patients in intensive care units. There has also been a marked increase in vancomycin-resistant enterococcal infections in surgical patients in the last 5 years. Some studies associate the prior use of vancomycin or third-generation cephalosporins with the emergence of these strains. Overall, enterococcal infections are associated with increased morbidity and mortality.
CONCLUSIONS: In view of the marked resistance of enterococci to antibiotics and their ability to disseminate resistance genes, these microbes have become important pathogens. Enterococci pose a threat to surgical patients, often causing significant therapeutic dilemmas.

Entities:  

Mesh:

Year:  1996        PMID: 8611101     DOI: 10.1001/archsurg.1996.01430150116021

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Perioperative antibiotics covering bile contamination prevent abdominal infectious complications after pancreatoduodenectomy in patients with preoperative biliary drainage.

Authors:  Takeshi Sudo; Yoshiaki Murakami; Kenichiro Uemura; Yasushi Hashimoto; Naru Kondo; Naoya Nakagawa; Hiroki Ohge; Taijiro Sueda
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

Review 2.  Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria.

Authors:  T Herzog; A M Chromik; Waldemar Uhl
Journal:  Eur J Med Res       Date:  2010-11-30       Impact factor: 2.175

3.  A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].

Authors:  María E Oliva; Arcot Rekha; Albert Yellin; Jacyr Pasternak; Maria Campos; Gilbert M Rose; Timothy Babinchak; Evelyn J Ellis-Grosse; Evan Loh
Journal:  BMC Infect Dis       Date:  2005-10-19       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.